AllianceBernstein’s Vericel Corp VCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.14M Buy
59,352
+711
+1% +$25.3K ﹤0.01% 1958
2025
Q4
$2.11M Buy
58,641
+6,265
+12% +$230K ﹤0.01% 1968
2025
Q3
$1.65M Buy
52,376
+76
+0.1% +$2.73K ﹤0.01% 2117
2025
Q2
$2.23M Sell
52,300
-2,439
-4% -$101K ﹤0.01% 1880
2025
Q1
$2.44M Buy
54,739
+9
+0% +$484 ﹤0.01% 1787
2024
Q4
$3.01M Sell
54,730
-3,160
-5% -$160K ﹤0.01% 1752
2024
Q3
$2.45M Sell
57,890
-25
-0% -$1.19K ﹤0.01% 1857
2024
Q2
$2.66M Hold
57,915
﹤0.01% 1794
2024
Q1
$3.01M Buy
57,915
+3,745
+7% +$164K ﹤0.01% 1697
2023
Q4
$1.93M Buy
54,170
+270
+0.5% +$9.4K ﹤0.01% 1954
2023
Q3
$1.81M Sell
53,900
-56,370
-51% -$1.95M ﹤0.01% 1933
2023
Q2
$4.14M Sell
110,270
-2,080
-2% -$68.4K ﹤0.01% 1510
2023
Q1
$3.29M Sell
112,350
-6,969
-6% -$202K ﹤0.01% 1591
2022
Q4
$3.14M Buy
119,319
+48
+0% +$1.14K ﹤0.01% 1652
2022
Q3
$2.77M Buy
119,271
+18,490
+18% +$504K ﹤0.01% 1675
2022
Q2
$2.54M Buy
100,781
+1,109
+1% +$32.7K ﹤0.01% 1794
2022
Q1
$3.81M Buy
99,672
+166
+0.2% +$5.99K ﹤0.01% 1713
2021
Q4
$3.91M Buy
99,506
+126
+0.1% +$5.52K ﹤0.01% 1754
2021
Q3
$4.85M Sell
99,380
-3,000
-3% -$155K ﹤0.01% 1627
2021
Q2
$5.38M Buy
102,380
+43,630
+74% +$2.49M ﹤0.01% 1572
2021
Q1
$3.26M Buy
58,750
+1,650
+3% +$74.7K ﹤0.01% 1812
2020
Q4
$1.76M Hold
57,100
﹤0.01% 2058
2020
Q3
$1.06M Hold
57,100
﹤0.01% 2158
2020
Q2
$789K Hold
57,100
﹤0.01% 2326
2020
Q1
$524K Sell
57,100
-1,900
-3% -$28.5K ﹤0.01% 2334
2019
Q4
$1.03M Hold
59,000
﹤0.01% 2269
2019
Q3
$893K Hold
59,000
﹤0.01% 2302
2019
Q2
$1.11M Buy
59,000
+16,600
+39% +$283K ﹤0.01% 2266
2019
Q1
$742K Hold
42,400
﹤0.01% 2383
2018
Q4
$738K Buy
42,400
+8,400
+25% +$126K ﹤0.01% 2333
2018
Q3
$481K Hold
34,000
﹤0.01% 2638
2018
Q2
$330K Buy
+34,000
New +$424K ﹤0.01% 2777
2014
Q3
Sell
-85
Closed 3474
2014
Q2
$0 Buy
+85
New +$352 ﹤0.01% 3639

Other funds holding VCEL

AllianceBernstein's VCEL Position: Q1 2026 in Review

AllianceBernstein increased its Vericel Corp (VCEL) stake by 1.2% in Q1 2026, buying an estimated $25.3K and bringing the position to 59,352 shares worth $2.14M. The position accounts for ﹤0.01% of the portfolio, ranked #1958.

AllianceBernstein first reported a position in VCEL in Q2 2014 and has held it in 33 quarters since. The position peaked at $5.38M in Q2 2021. 279 funds tracked by Wall St. Rank hold VCEL as of Q1 2026.

  • AllianceBernstein held 59,352 shares of Vericel Corp worth $2.14M as of Q1 2026.
  • AllianceBernstein bought 711 Vericel Corp shares in Q1 2026, an estimated $25.3K.
  • Vericel Corp made up ﹤0.01% of AllianceBernstein's portfolio in Q1 2026, its #1958 holding.
  • AllianceBernstein first reported a position in Vericel Corp in Q2 2014 and has held it in 33 quarters since.
  • AllianceBernstein's Vericel Corp position peaked at $5.38M in Q2 2021.
  • 279 funds tracked by Wall St. Rank held Vericel Corp as of Q1 2026.

Based on AllianceBernstein's 13F filing for Q1 2026, filed 15 May 2026.